Vaporox Support and Resources
Enter your Customer ID and view our customer resources
Latest Resources
This page provides quick references but the complete instructions for use are available in the user manual.
FAQs
Yes. VHT is an adjunt therapy and may be used with cellular tissue products. Feel free to view a letter from one of our providers, Jason Harrill, D.P.M, who highlights VHT usage with cellular tissue based products here.
VHT is clinically validated to treat nine types of post-acute wounds, including stalled and hard-to-heal wounds. It’s particularly effective in cases where conventional treatments have been less successful.
VHT can treat any chronic wounds that are documented as failing standard of care for 30 days or more.
Yes. Vaporox has a category 1 CPT billing code.
Standard wound care + VHT = 84%. You can additionally view Dr. Kruse’s, DPM, MA, FAFAS, letter on VHT and it’s positive effects on contributing to rapid wound granulation here.
VHT is an adjunct therapy that supplements standard wound care and other advanced modalities, allowing next-generation technology to be adopted effortlessly with no capital investment.
No. If the wound is chronic, its etiology, size, and location does not matter.
Contact our sales team to see if your practice or facility qualifies for Vaporox placement. Get in touch.